Crossmark

Development of a risk model for outcome prediction and treatment guidance in lung adenocarcinoma based on hypoxia, glycolysis, and lymph node metastasis-related genes

Crossref DOI link: https://doi.org/10.1007/s12672-026-04805-8

Published Online: 2026-04-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Ze

Wang, Yu
License Information

Text and Data Mining valid from 2026-04-22

Accepted Manuscript valid from 2026-04-22
More Information

Article History

Received: 28 September 2025

Accepted: 4 March 2026

First Online: 22 April 2026

Declarations

:

: The present study was approved by the Ethics Committee of The Second Affiliated Hospital of Dalian Medical University (No. 2023021). This study complied with the Declaration of Helsinki. The written informed consent was obtained from the all patients.

: The written informed consent was obtained from the all patients.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below